psychedelics
MindMed sets milestone in finding psychedelic cure for opioid addiction
The company has come up with a derivative of ibogaine, a psychoactive substance from an African shrub.
PharmaTher advances in work to develop microneedle patch for psychedelics
Toronto company seeks to come up with alternative way to administer psychedelic substances.
Optimi Health completes development of mushroom facility in B.C.
The Vancouver functional and psychedelic fungi company has applied for a Health Canada dealer’s licence.
Vancouver cannabis processor Nextleaf applies for psychedelics licence
The Vancouver-based company wants to engage in range of activities related to psilocybin and psilocin.
Marvel Biosciences starts work on psychedelics-inspired compounds
The Calgary-based life sciences company hopes to develop treatments for mental health conditions.
Love Pharma to develop psilocybin-infused oral strips
Sublingual or the administration of medicines under the tongue allows for quick absorption.
Cybin Inc. seeks patent for inhalation delivery of psychedelic medications
The Toronto company is developing a psychedelic drug for anxiety disorders.
Academic reflects on bioethical issues in medicalization of psychedelics
Australian researcher cites need to explore ethical issues regarding the use of psychedelics as medicine.
Nova Mentis looks at potential psilocybin treatment for obesity and diabetes
People with obesity and diabetes may have an alternative way to get better with the psychedelic substance psilocybin.